Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome

Date
2015
Author
KESKİN, ONUR
Wedemeyer, Heiner
Pehlivan, Selcen
Zeuzem, Stefan
YALÇIN, KENDAL
Gurel, Selim
İDİLMAN, RAMAZAN
BOZKAYA, HAKAN
Manns, Michael
Yurdaydin, Cihan
Tabak, Fehmi
Tuzun, Ali
Zachou, Kalliopi
Deda, Xheni
Dalekos, George N.
Heidrich, Benjamin
Metadata
Show full item record
Abstract
BACKGROUND & AIMS: Interferon is the only effective treatment for chronic hepatitis D virus (HDV) infection. No rules have been set for stopping treatment based on viral kinetics. We analyzed data from an international study of hepatitis D treatment to identify factors associated with outcomes of pegylated interferon treatment, with and without adefovir.
URI
http://hdl.handle.net/20.500.12627/22065
https://doi.org/10.1016/j.cgh.2015.05.029
Collections